Connect with us

Science

Could protein barcodes speed up drug development? Manifold Bio scores $5.4 million to find out – FierceBiotech

There is no shortage of biotech startups working to streamline drug discovery, but those efforts are concentrated at the earliest stages of drug discovery and sooner or later, all drug developers run into the same bottleneck: preclinical testing. Manifold Bio…

Published

on

There is no shortage of biotech startups working to streamline drug discovery, but those efforts are concentrated at the earliest stages of drug discovery and sooner or later, all drug developers run into the same bottleneck: preclinical testing.
While animal studies are not a perfect mirror of how a drug might work in humans, they are still the best proxy for a disease, said Gleb Kuznetsov, Ph.D., CEO and co-founder of Manifold Bio, a startup out of the laboratory of George Church, Ph.D., that…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending